Patent · US Active

Inhibitors of protein kinases

US8518948B2 · kind B2 · utility

0Cited by

1References

16Claims

0Family size

Assignee

Ingenium Pharmaceuticals GmbH · DE

Inventors

Lutz Zeitlmann · Munich, DE
Andre Niestroj · Halle (Saale), DE
Ulrich Heiser · Halle (Saale), DE

Key dates

Filing date	Mar 10, 2011
Grant date	Aug 27, 2013
Priority date	—
Expiry date	Jul 28, 2031

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of general Formula (I):wherein R1, R2, R3, Ra, A, B and x are as defined herein are inhibitors of protein kinases in particular members of the cyclin-dependent kinase family and/or the glycogen synthase kinase 3 family and are useful in preventing and/or treating any type of pain, inflammatory disorders, cancer, immunological diseases, proliferative diseases, infectious diseases, cardiovascular diseases, metabolic disorders, renal diseases, neurologic and neuropsychiatric diseases and neurodegenerative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.